FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Nalbuphine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 10/11/2019
»Therapeutic Categories: Analgesia/Addiction

Expand all

Hospira, Inc. (Revised 05/20/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL; 1 mL Glass Ampul (NDC 00409-1463-01) Next Delivery and Estimated Recovery: December 2020 Shortage of an active ingredient

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
20 mg/mL; 1 mL Glass Ampul (NDC 00409-1465-01) Next Delivery and Estimated Recovery: December 2020 Shortage of an active ingredient

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1464-01) Limited Supply Available. Next Delivery and Estimated Recovery: December 2020 Shortage of an active ingredient

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other
200 mg/10 mL (20 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1467-01) Next Delivery and Estimated Recovery: December 2020 Shortage of an active ingredient

Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English